Back
Intra-Cellular Therapies Stock Price Chart
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Buy
54
ITCI
Intra-Cellular Therapies
Last Price:
85.35
Seasonality Move:
25.32%
7 Day Trial
ALL ACCESS PASS
$
7
The $6 Billion Income Secret of the World's Most Successful Investor
Discover the 3-step trick to finding top dividend stocks to buy and hold forever- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.
Intra-Cellular Therapies Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 78.42 | Buy |
| 20-day SMA: | 75.93 | Buy |
| 50-day SMA: | 74.9 | Buy |
| 200-day SMA: | 71.73 | Buy |
| 8-day EMA: | 79.67 | Buy |
| 20-day EMA: | 77.15 | Buy |
| 50-day EMA: | 75.58 | Buy |
| 200-day EMA: | 71.3 | Buy |
Intra-Cellular Therapies Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.86 | Buy |
| Relative Strength Index (14 RSI): | 71.95 | Buy |
| Chaikin Money Flow: | -881648 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (71.93 - 78.75) | Buy |
| Bollinger Bands (100): | (71.47 - 77.97) | Buy |
Intra-Cellular Therapies Technical Analysis
| Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intra-Cellular Therapies Stock
Is Intra-Cellular Therapies Stock a Buy?
- Intra-Cellular Therapies share price is 84.75 while ITCI 8-day simple moving average is 78.42, which is a Buy signal.
- The stock price of ITCI is 84.75 while Intra-Cellular Therapies 20-day SMA is 75.93, which makes it a Buy.
- Intra-Cellular Therapies 50-day simple moving average is 74.90 while ITCI share price is 84.75, making it a Buy technically.
- ITCI stock price is 84.75 and Intra-Cellular Therapies 200-day simple moving average is 71.73, creating a Buy signal.
ITCI Technical Analysis vs Fundamental Analysis
Buy
54
Intra-Cellular Therapies (ITCI)
is a Buy
Is Intra-Cellular Therapies a Buy or a Sell?
-
Intra-Cellular Therapies stock is rated a Buy
The current Intra-Cellular Therapies [ITCI] share price is $84.75. The Score for ITCI is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Intra-Cellular Therapies Stock Info
Market Cap:
8.98B
Price in USD:
84.75
Share Volume:
1.04M
Intra-Cellular Therapies 52-Week Range
52-Week High:
88.00
52-Week Low:
50.87
Buy
54
Intra-Cellular Therapies (ITCI)
is a Buy
Intra-Cellular Therapies Share Price Forecast
-
What is the Intra-Cellular Therapies stock price today?
The Intra-Cellular Therapies stock price is 84.75 USD today. -
Will ITCI stock go up or go down?
Intra-Cellular Therapies> share price is forecast to RISE/FALL based on technical indicators -
Is Intra-Cellular Therapies overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intra-Cellular Therapies is not overvalued.
Is Intra-Cellular Therapies Stock a Buy?
- Intra-Cellular Therapies share price is 84.75 while ITCI 8-day exponential moving average is 79.67, which is a Buy signal.
- The stock price of ITCI is 84.75 while Intra-Cellular Therapies 20-day EMA is 77.15, which makes it a Buy.
- Intra-Cellular Therapies 50-day exponential moving average is 75.58 while ITCI share price is 84.75, making it a Buy technically.
- ITCI stock price is 84.75 and Intra-Cellular Therapies 200-day simple moving average is 71.30, creating a Buy signal.
Fundamental Analysis of Intra-Cellular Therapies
Is Intra-Cellular Therapies a good investment?
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.93 per share, and an increase next year of $1.08 per share.
Technical Analysis of Intra-Cellular Therapies
Should I short Intra-Cellular Therapies stock?
- ITCI Moving Average Covergence Divergence (MACD) indicator is 1.86, suggesting Intra-Cellular Therapies is a Buy
- Intra-Cellular Therapies Relative Strength Index (RSI) is 71.95, which suggest Intra-Cellular Therapies is overbought
- The Bollinger Bands (25) for Intra-Cellular Therapies is (71.93 - 78.75), which suggest Intra-Cellular Therapies is a Buy
- The Bollinger Bands (100) for Intra-Cellular Therapies is (71.47 - 77.97), which suggest Intra-Cellular Therapies is a Buy
* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.